Showing results (1211-1220 of 1,246) with videos related to

Sort By:
Pageof 125
Experimental Oncology|June 27, 2015
Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16N I Fedosova, I M Voeykova, О М Karaman, et al.
Experimental Oncology|June 27, 2015
Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factorO O Shevchuk, К А Posokhova, I N Todor, et al.
Experimental Oncology|June 27, 2015
Survival rates of familial and sporadic prostate cancer patientsJ Plonis, M Nakazawa-Miklasevica, A Malevskis, et al.
Experimental Oncology|August 14, 2022
ONCOLYTIC ACTIVITY OF HUMAN ORTHOPNEUMOVIRUS IN CANCER CELL LINESI M Aziz, R Bhat, M A Farrag, et al.
Experimental Oncology|August 14, 2022
EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLSR Parra-Medina, C Payán-Gómez, N L Acosta-Vega, et al.
Experimental Oncology|August 14, 2022
OECI 2022 ONCOLOGY DAYS AND GENERAL ASSEMBLYErnestas Janulionis
Experimental Oncology|August 14, 2022
THE CHANGES OF NO LEVEL AND RNase ACTIVITY IN TUMOR TISSUE ACCOMPANYING THE PROGRESSION OF PROSTATE CANCERA P Burlaka, S V Virko, V M Grygorenko, et al.
Experimental Oncology|July 17, 2025
IMMUNOHISTOCHEMICAL STUDY OF CD44 AND OCT3/4 EXPRESSION IN COLORECTAL CANCER SAMPLES OF IRAQI PATIENTSNoah A MahmoodМахмуд, Firas S Salah, Zaynab S Abdulghany, et al.
Experimental Oncology|July 17, 2025
ERRATUM FOR CYSTECTOMY IN METASTATIC BLADDER CANCER: FEASIBILITY, SAFETY AND OUTCOMES PUBLISHED IN EXP ONCOL 2024;46(4)
Experimental Oncology|July 17, 2025
CORRELATION OF APOPTOSIS MARKERS LEVELS WITH THE DEVELOPMENT OF HEPATIC FAILURE IN MALIGNANT OBSTRUCTIVE JAUNDICEO Dronov, I Kovalska, L Roshchyna, et al.
Pageof 125